Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.
Quilici
Marie Laure
ML
Massenet
Denis
D
Gake
Bouba
B
Bwalki
Barem
B
Olson
David M
DM
D000900:Anti-Bacterial Agents; D002771:Cholera / Q000453:epidemiology* / Q000382:microbiology*; D002772:Cholera Toxin / Q000235:genetics; D002939:Ciprofloxacin / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009549:Nigeria / Q000453:epidemiology; D016133:Polymerase Chain Reaction; D041241:Vibrio cholerae O1 / Q000187:drug effects* / Q000235:genetics*
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002772:Cholera Toxin